InterCure
Non Invasive Medical Device for Hypertension Treatment.
Launch date
Employees
Market cap
€82.4m
Enterprise valuation
€114m (Public information from Sep 2024)
Share price
$1.86 INCR
Rishon LeTsiyon Center District (HQ)
Financials
Estimates*
ILS | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Revenues | - | 8.9m | 65.0m | 220m | 389m | 391m | 1.3b |
% growth | - | - | 629 % | 238 % | 77 % | 1 % | 235 % |
EBITDA | - | (21.2m) | 1.8m | 37.6m | 64.5m | 46.6m | (31.3m) |
% EBITDA margin | - | (238 %) | 3 % | 17 % | 17 % | 12 % | (2 %) |
Profit | - | (3.0m) | (37.2m) | 4.7m | 44.8m | (62.0m) | (70.4m) |
% profit margin | - | (34 %) | (57 %) | 2 % | 12 % | (16 %) | (5 %) |
EV / revenue | - | 44.1x | 6.3x | 3.8x | 1.5x | 0.8x | 0.1x |
EV / EBITDA | - | -18.6x | 225.8x | 22.5x | 8.9x | 6.6x | -1.9x |
R&D budget | - | 1.7m | 1.6m | 1.2m | <1m | <1m | - |
R&D % of revenue | - | 19 % | 2 % | 1 % | - | - | - |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | $5.0m | Post IPO Equity | |
Total Funding | - |
Related Content
Recent News about InterCure
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.